AVTEMDRIA Trademark

Trademark Overview

On Thursday, April 28, 2022, a trademark application was filed for AVTEMDRIA with the United States Patent and Trademark Office. The USPTO has given the AVTEMDRIA trademark a serial number of 97386045. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Tuesday, October 29, 2024. This trademark is owned by Allergan Pharmaceuticals International Limited. The AVTEMDRIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations to treat infections
avtemdria

General Information

Serial Number97386045
Word MarkAVTEMDRIA
Filing DateThursday, April 28, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateTuesday, October 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 23, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations to treat infections

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 3, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAllergan Pharmaceuticals International Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDublin D17E400
IE
Party NameAllergan Pharmaceuticals International Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDublin D17 E400
IE

Trademark Events

Event DateEvent Description
Thursday, October 13, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 2, 2022NEW APPLICATION ENTERED
Tuesday, May 3, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 11, 2022ASSIGNED TO EXAMINER
Thursday, October 13, 2022NON-FINAL ACTION WRITTEN
Thursday, October 13, 2022NON-FINAL ACTION E-MAILED
Thursday, April 13, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 13, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 14, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 20, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, April 20, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, April 20, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, April 20, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 3, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 23, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 23, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 18, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 17, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, January 17, 2024SOU EXTENSION 1 FILED
Wednesday, January 17, 2024SOU EXTENSION 1 GRANTED
Friday, January 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 10, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, July 10, 2024SOU EXTENSION 2 FILED
Wednesday, July 10, 2024SOU EXTENSION 2 GRANTED
Tuesday, October 29, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, October 29, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 29, 2024SOU EXTENSION 3 FILED
Tuesday, October 29, 2024SOU EXTENSION 3 GRANTED
Wednesday, July 10, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

avtemdria infections treat preparations pharmaceutical